Oaktree SPAC Sets October 16 Vote to Extend Business Combination Deadline to May 2027
OACC is trading near its 52-week low of $10.3 (4.5% above the low) on elevated volume (5.0× avg).
Summary
Oaktree Acquisition Corp. III Life Sciences has filed its definitive proxy for an October 16 shareholder vote to extend its business combination deadline from October 25, 2026 to as late as May 25, 2027. Without approval, the SPAC would liquidate and return approximately $10.75 per share to public shareholders.
Key Events · Corporate Governance and Compliance · OACC
-
Extension Vote Scheduled for October 16
Shareholders will vote on extending the business combination deadline from October 25, 2026 to November 25, 2026, with up to six additional one-month extensions through May 25, 2027.
-
Redemption Price Set at $10.75
Trust Account holds approximately $206.3 million as of September 30, 2026, equating to a redemption price of $10.75 per share — just $0.03 below the October 1 closing price of $10.78.
-
Liquidation Risk Without Approval
If the extension is not approved and no business combination is completed by October 25, 2026, OAC will liquidate and return approximately $10.75 per share to public shareholders; warrants would expire worthless.
-
Sponsor Commits 21.9% Stake in Favor
The Sponsor holds 5,383,739 Ordinary Shares (21.9% of outstanding) and intends to vote in favor, but approval still requires at least 11,004,774 public shares if all shares are voted.
Analysis · OACC · Real Estate & Construction
Shareholders are being asked to approve an extension of the business combination deadline from October 25, 2026 to November 25, 2026, with the option for six additional one-month extensions through May 25, 2027. Without approval, the SPAC would be forced to liquidate and return approximately $10.75 per share to public shareholders. The redemption price sits just $0.03 below the current market price of $10.78, giving shareholders little financial incentive to redeem rather than sell on the open market. The Sponsor, holding 21.9% of shares, has committed to vote in favor, but approval still requires significant public shareholder support — at least 11,004,774 public shares if all shares are voted. The company has reiterated its going concern warning and has not yet identified a target, making this vote a critical juncture between continued pursuit of a deal and liquidation.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.5% of the 1629 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OACC was trading at $10.76 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $264.5M. The 52-week trading range was $10.30 to $10.88. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.